Yu, Yilin
Wu, Junxin
Wu, Haixia
Wang, Zhiping
Wu, Shiji
Hong, Liang
Xu, Benhua
Shao, Lingdong
Funding for this research was provided by:
the National Clinical Key Specialty Construction Program (2021, 2021)
the Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012, 2020Y2012)
Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies (2021Y2014, 2021Y2014)
Article History
Received: 20 July 2023
Accepted: 28 October 2023
First Online: 10 November 2023
Declarations
:
: The current study was approved by the ethics committee of Fujian Medical University Cancer Hospital (K2021-050–01), Fuzhou, China, and conducted in accordance with the principles of the Declaration of Helsinki and its amendment. All patients provided written informed consent prior to treatment, and all the information was anonymized prior to analysis.
: The manuscript has been approved by all authors for publication.
: The authors declare no competing interests.